Results

60 stories for“regulation”

Shortages pushed patients toward compounded semaglutide. The FDA's latest alert shows why that workaround carries real risk.

Aug 5, 2024

Health

Ozempic and Wegovy: What the Trials Actually Showed

Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.

Mar 13, 2024

Health

Gut Microbiome Testing: What It Can and Cannot Tell You Today

Mail-in stool tests promise personalized nutrition insight, but the same sample sent to different labs can come back with conflicting advice.

Oct 3, 2025

Health

Sleep Economy: Tracking, Hacking, Buying Rest

The sleep industry hits $585 billion as Americans invest in mattresses, trackers, and supplements to optimize rest. But obsessing over sleep data might actually backfire.

Feb 15, 2024

Health

The GLP-1 Era: How Weight-Loss Drugs Changed Us

Semaglutide and tirzepatide went from diabetes treatment to celebrity shortcut to a genuine health story. What happens when one drug becomes a cultural moment.

Apr 20, 2024

Health

GLP-1 Side Effects and Who Should Not Take Them

Nausea is the least of it. Here is an honest look at GLP-1 side effects, the thyroid warning, pancreatitis and who is advised to avoid them.

Jul 10, 2024

Health

France’s June Heatwave Toll: 5,764 Excess Deaths in 2026

A delayed mortality count reveals the June heatwave’s true scale, showing why the deadliest climate disaster can pass quietly behind ordinary causes of death.

Jul 23, 2026

Health

PRIMA’s Retinal Implant Wins Approval to Restore Vision

A tiny implant paired with camera glasses can return useful central vision to some people with advanced macular degeneration, and Europe has cleared its sale.

Jul 23, 2026